Michael McElhaugh
Chief Executive Officer at ARBUTUS BIOPHARMA CORPORATION
Net worth: 4 M $ as of 2024-04-29
Network origin in Michael McElhaugh first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 41 | |
Pharmasset, Inc.
 Pharmasset, Inc. Pharmaceuticals: OtherHealth Technology Pharmasset, Inc. developed drugs to treat viral infections. It focued in the development of oral therapeutics for the treatment of hepatitis C virus (HCV) infection. The company was founded in 1998 and was headquartered in Princeton, NJ.
23
| Subsidiary | Pharmaceuticals: Other | 23 |
Arbutus Biopharma, Inc.
 Arbutus Biopharma, Inc. BiotechnologyHealth Technology Arbutus Biopharma, Inc. engages in the research and development of pharmaceutical products for Hepatitis B. Its operation includes covalently closed circular DNA, Capsid Assembly, Cyclophilins, and Surface Antigen. The company was founded by Patrick T. Higgins, Michael J. Sofia, Michael J. McElhaugh, and Bryce A. Roberts in May 2012 and is headquartered in Doylestown, PA.
2
| Subsidiary | Biotechnology | 2 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Michael McElhaugh via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| GILEAD SCIENCES, INC. | Biotechnology | Chief Executive Officer Director of Finance/CFO Corporate Officer/Principal General Counsel Chief Tech/Sci/R&D Officer Compliance Officer Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
Roivant Sciences, Inc.
 Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member Corporate Officer/Principal Chief Executive Officer Corporate Officer/Principal President | |
| MYOVANT SCIENCES LTD. | Biotechnology | Director of Finance/CFO Chairman Director/Board Member Director/Board Member Chairman | |
| University of British Columbia | College/University | Corporate Officer/Principal Undergraduate Degree Doctorate Degree Undergraduate Degree | |
Genevant Sciences Corp.
 Genevant Sciences Corp. Pharmaceuticals: MajorHealth Technology Part of Roivant Sciences Ltd., Genevant Sciences Corp. operates as a Canadian biopharmaceutical company. The company is based in Burnaby, Canada. The CEO of the company is Bo Rode Hansen. | Pharmaceuticals: Major | Director/Board Member Chairman Chief Executive Officer Director/Board Member | |
| SIO GENE THERAPIES INC. | Pharmaceuticals: Major | Director/Board Member Chairman Chief Executive Officer Director/Board Member | |
| IMMUNOVANT, INC. | Biotechnology | Director/Board Member Chairman Director/Board Member | |
Altavant Sciences, Inc.
 Altavant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Altavant Sciences, Inc. is a clinical stage biopharmaceutical company, which provides therapies that treat respiratory diseases with an initial therapeutic focus in pulmonary arterial hypertension (PAH). The company is headquartered in Cary, NC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chief Executive Officer | |
| ROIVANT SCIENCES LTD. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer President | |
| EUPRAXIA PHARMACEUTICALS INC. | Biotechnology | Director of Finance/CFO Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
Gilead Connecticut, Inc.
 Gilead Connecticut, Inc. Pharmaceuticals: MajorHealth Technology Gilead Connecticut, Inc. manufactures pharmaceuticals and biotechnology chemicals. The firm develops a pipeline of small molecule therapeutics for multiple oncology and immunology-based indications. It focuses on the development of novel kinase inhibitors for the treatment of cancer, autoimmune, and inflammatory diseases. The company was founded in 2000 and is headquartered in Foster City, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Gilead Sciences GmbH
 Gilead Sciences GmbH Pharmaceuticals: MajorHealth Technology Part of Gilead Sciences, Inc., Gilead Sciences GmbH is a German company that manufactures and supplies medicines. The company is based in Martinsried, Germany. The CEOs are Carsten Nowotsch, Brett A. Pletcher, Robin L. Washington. The company was founded in 1991. | Pharmaceuticals: Major | Chief Executive Officer Chief Executive Officer | |
Gilead Sciences International Ltd.
 Gilead Sciences International Ltd. Other Consumer ServicesConsumer Services Founded in 1996, Gilead Sciences International Ltd. is a subsidiary of Gilead Sciences, Inc. The company is based in Cambridge, UK. Gilead Sciences International is focused on developing and delivering medications that advance the treatment of life-threatening diseases. Contact information, addresses, and directions for all of Gilead U.S. locations can be found on their website. Additionally, contact details for Gilead offices in other locations are also available. | Other Consumer Services | Director/Board Member Director/Board Member | |
Dermavant Sciences, Inc.
 Dermavant Sciences, Inc. BiotechnologyHealth Technology Part of Roivant Sciences Ltd., Dermavant Sciences, Inc. develops biological products. The company is based in Raleigh, NC. Todd Zavodnick has been the CEO of the company since 2018. | Biotechnology | Director/Board Member Chairman | |
Gilead Sciences Ltd.
 Gilead Sciences Ltd. Medical DistributorsDistribution Services Founded in 1990, Gilead Sciences Ltd. is a pharmaceutical wholesaler that is part of Gilead Sciences, Inc. The company is based in London, UK and specializes in the distribution of pharmaceutical products. | Medical Distributors | Director/Board Member Director/Board Member | |
Gilead Sciences Europe Ltd.
 Gilead Sciences Europe Ltd. Pharmaceuticals: MajorHealth Technology Part of Gilead Sciences, Inc., Gilead Sciences Europe Ltd. develops and commercializes pharmaceuticals. The company is based in London, UK. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| KITE PHARMA INC | Biotechnology | Director of Finance/CFO Corporate Secretary | |
Ernst & Young LLP
 Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| UROVANT SCIENCES LTD. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| INMED PHARMACEUTICALS INC. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
Kite Pharma UK Ltd.
 Kite Pharma UK Ltd. Miscellaneous Commercial ServicesCommercial Services Founded in 2014, Kite Pharma UK Ltd. is a subsidiary of Gilead Sciences, Inc. that engages in research and develops clinical trials. The company is based in London, UK. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| UNILIFE CORP | Medical Specialties | Director of Finance/CFO Compliance Officer | |
| Yale School of Medicine | College/University | Corporate Officer/Principal Doctorate Degree | |
| INTERCEPT PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| Simon Fraser University | College/University | Undergraduate Degree Undergraduate Degree | |
Sumitomo Pharma America, Inc.
 Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | Pharmaceuticals: Major | Chief Executive Officer Director of Finance/CFO | |
Urovant Sciences, Inc.
 Urovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sumitomo Chemical Co., Ltd., Urovant Sciences, Inc. is a pharmaceutical company that prioritizes diversity, equity, and inclusion in rewriting how care is provided in urology. The company is based in Irvine, CA and offers programs to improve patient care, with a current focus on overactive bladder. Urovant Sciences is expanding opportunities to help patients in and beyond, with links to marketed product sites for patients and healthcare professionals, plus patent information. Recently, Sumitovant Biopharma Ltd. announced that its parent company Sumitomo Pharma Co., Ltd. will combine its wholly owned subsidiaries to form Sumitomo Pharma America, Inc., which will include Urovant Sciences and other subsidiaries. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| CHIMERIX, INC. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
Pulmocide Ltd.
 Pulmocide Ltd. Pharmaceuticals: MajorHealth Technology Pulmocide Ltd. provides biopharmaceutical services. It develops inhaled medicines for viral and fungal infections of the respiratory tract. The company was founded by William Garth Rapeport, John Murray, Kazuhiro Ito, and Peter Strong on March 23, 2007 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
Dermavant Sciences Ltd.
 Dermavant Sciences Ltd. Pharmaceuticals: MajorHealth Technology Dermavant Sciences Ltd. is a clinical-stage biopharmaceutical company which focuses on developing and commercializing therapeutics in medical dermatology. The company is developing a pipeline of therapies in medical dermatology and is currently advancing development programs for five product candidates which targets specific unmet needs in two of the immuno-dermatology markets, psoriasis and atopic dermatitis, as well as other large markets, including vitiligo, primary focal hyperhidrosis and acne. The company was founded on September 28, 2015 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Chairman | |
Roivant Sciences GmbH
 Roivant Sciences GmbH Pharmaceuticals: MajorHealth Technology Roivant Sciences GmbH engages in the development and marketing of biopharmaceutical products. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Operating Officer | |
Sumitovant Biopharma, Inc.
 Sumitovant Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Sumitovant Biopharma, Inc. provides biotechnology services. It offers oncology, gene therapy, rare, pulmonary, urological disease, digital innovation and novel platforms. The company is headquartered in New York, NY. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
Global Virus Network
 Global Virus Network Miscellaneous Commercial ServicesCommercial Services Global Virus Network conducts research on essential and critical defense against viral diseases. The non-profit company is based in Baltimore, MD. The company was founded by William Walmsley Hall and Robert C. Gallo. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| ASTRAZENECA PLC | Pharmaceuticals: Major | Founder Corporate Officer/Principal | |
Antios Therapeutics, Inc.
 Antios Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Antios Therapeutics, Inc. operates as a biopharmaceutical company devoted to developing therapies for viral diseases. The company was founded by Abel De La Rosa, Doug Mayers and Idean Marvasty on October 30, 2018 and is headquartered in Atlanta, GA. | Pharmaceuticals: Major | Director/Board Member Founder | |
| REGENERON PHARMACEUTICALS, INC. | Pharmaceuticals: Major | General Counsel Director of Finance/CFO | |
| University of Wisconsin | College/University | Undergraduate Degree Undergraduate Degree | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Comptroller/Controller/Auditor Corporate Officer/Principal | |
Axovant Sciences, Inc.
 Axovant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Sio Gene Therapies, Inc., Axovant Sciences, Inc. is a company that manufactures and distributes pharmaceutical products. The company is based in New York, NY. | Pharmaceuticals: Major | Chairman Chief Executive Officer |
Statistics
International
| United States | 26 |
| United Kingdom | 13 |
| Canada | 12 |
| Germany | 2 |
| Switzerland | 2 |
Sectoral
| Health Technology | 40 |
| Consumer Services | 7 |
| Commercial Services | 4 |
| Finance | 2 |
| Distribution Services | 2 |
Operational
| Director/Board Member | 267 |
| Corporate Officer/Principal | 120 |
| Independent Dir/Board Member | 71 |
| Chairman | 59 |
| Chief Executive Officer | 50 |
Most connected contacts
| Insiders | |
|---|---|
| G. Steven Burrill | 44 |
| Myrtle Potter | 41 |
| Frank Torti | 35 |
| Robin Washington | 34 |
| Ken Galbraith | 30 |
| Daniel Burgess | 28 |
| Fredric D. Price | 16 |
| Adam Daniel Cutler | 16 |
| Michael Jeffrey Abrams | 16 |
| Richard Henriques | 15 |
| Brett Pletcher | 15 |
| Keith Manchester | 15 |
| Vivek Ramaswamy | 14 |
| Paul A. Brennan | 14 |
| Bruce G. Cousins | 14 |
- Stock Market
- Insiders
- Michael McElhaugh
- Company connections
